Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter
breadcrumb banner

IAVI

Search

Categories

Recent Posts

Post Image

One Million More Midwives: The Smartest Investment for Safer Births in a Shrinking Aid Landscape

May 11, 2026
Post Image

Curated Conversations: Isra Chaker on Reimagining Maternal Health Philanthropy and Saving Mothers’ Lives

May 11, 2026
Post Image

Beauty Without Burden: Why Nigeria Must Keep Lead Out of Cosmetics

May 11, 2026
Post Image

Twice-Yearly Lenacapavir Injection for HIV Prevention in Nigeria: The Real Test Is Access

May 11, 2026
Post Image

How FOR M(om) is Pushing for Safer Medical Waste Management in Kano Hospitals

May 11, 2026
Blog Image
By

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways • Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 clinical trial of any Lassa vaccine.• Lassa fever is a deadly hemorrhagic fever common to West Africa. […]

Read More